# Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.

> **NCT01936649** · PHASE4 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 63 (actual)

## Conditions studied

- Heart Failure (HF)
- Ventricular Dysfunction, Left

## Interventions

- **DRUG:** AdreView (Iobenguane I 123 Injection)

## Key facts

- **NCT ID:** NCT01936649
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2016-12-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01936649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01936649, "Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01936649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*